I bought in November at $9.XX because I thought the share price had overreacted to some negative comments by a blogger. I'm thinking of selling soon, and would like to know the thought processes of people buying now.
Thanks for the info. Even if a PDP or ADP patient is at home, it seems unlikely he is responsible for ordering his own medications.
I suspect many or most of the target patients are institutionalized and will get Nup through their institution.
It would be risky for their reps to talk about the top line data, I expect they will wait for publication of the complete results in a peer-reviewed journal.
I think it could go either way. They have to be prepared to go it alone, and talk that way, in order to elicit fair bids to buy out the company.